propafenone has been researched along with Psoriasis in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capella, GL | 1 |
| Palleschi, GM | 1 |
| Bellandi, S | 1 |
| Torchia, D | 1 |
2 other studies available for propafenone and Psoriasis
| Article | Year |
|---|---|
[Psoriasis worsened by propafenone].
Topics: Aged; Anti-Arrhythmia Agents; Humans; Male; Propafenone; Psoriasis; Severity of Illness Index; Tachy | 2005 |
Propafenone-induced psoriasis.
Topics: Aged; Anti-Arrhythmia Agents; Female; Humans; Propafenone; Psoriasis; Treatment Outcome | 2008 |